Technical Analysis for CDAK - Codiak BioSciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | N/A |
| Historical CDAK trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| New 52 Week Closing Low | Bearish | 2.01% | |
| Hot IPO Pullback | Bullish Swing Setup | 2.01% | |
| NR7 | Range Contraction | 2.01% | |
| Inside Day | Range Contraction | 2.01% | |
| Down 3 Days in a Row | Weakness | 2.01% | |
| New 52 Week Closing Low | Bearish | -1.33% | |
| Hot IPO Pullback | Bullish Swing Setup | -1.33% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Reversed from Up | 3 days ago | |
| Up 2% | 3 days ago | |
| Gap Up Closed | 3 days ago | |
| Down 3% | 3 days ago | |
| Down 2 % | 3 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
Biopharmaceutical Life Sciences Biology Diseases Disease Infectious Disease Exosome Vesicles Neuromuscular Disease
Biopharmaceutical Life Sciences Biology Diseases Disease Infectious Disease Exosome Vesicles Neuromuscular Disease
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 14.4 |
| 52 Week Low | 9.05 |
| Average Volume | 407,993 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 0.00 |
| Average True Range | 0.00 |
| ADX | 0.0 |
| +DI | 0.00 |
| -DI | 0.00 |
| Chandelier Exit (Long, 3 ATRs ) | N/A |
| Chandelier Exit (Short, 3 ATRs ) | N/A |
| Upper Bollinger Band | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.42 | ||||
| Resistance 3 (R3) | 10.34 | 10.00 | 10.28 | ||
| Resistance 2 (R2) | 10.00 | 9.80 | 10.04 | 10.24 | |
| Resistance 1 (R1) | 9.81 | 9.67 | 9.91 | 9.89 | 10.19 |
| Pivot Point | 9.47 | 9.47 | 9.52 | 9.51 | 9.47 |
| Support 1 (S1) | 9.28 | 9.27 | 9.38 | 9.36 | 9.05 |
| Support 2 (S2) | 8.94 | 9.14 | 8.98 | 9.00 | |
| Support 3 (S3) | 8.75 | 8.94 | 8.96 | ||
| Support 4 (S4) | 8.83 |
